Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Psychedelics companies Cybin Inc. (NYSE: CYBN) and Small Pharma Inc. (OTCQB: DMTTF) have completed their August acquisition agreement. Following their...
The field of psychedelic research lost one of the greats on October 16, 2023. Join us in celebrating the life and contribution of Roland Griffiths.
All participants in the placebo group reported a 50 per cent drop in depression symptoms after surgery The post Believing you took ketamine during surgery...
“The hallmark feature of the mystical experience, that we can now occasion with high probability, is the sense of the interconnectedness of all things...
Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF)has gotten the green light for its deal with Cybin Inc. (NYSE American:CYBN) (NEO:CYBN). Small Pharma announced...
A new study into the therapeutic effects of psilocybin suggests that use of the psychedelic drug can help ease psychological distress in people who had...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Cybin Inc. (NYSE AMERICAN:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
This past quarter has been, without a doubt, the busiest and most transformative three months of this year— perhaps even of the entire history of the...